Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications

Cumara B. O'carroll; Maria I. Aguilar

doi:10.1177/1941874415587680

Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications

Cumara B. O'carroll, Maria I. Aguilar

Neurology

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Abstract

Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and shown to improve long-term functional outcomes. Its use is associated with an increased risk of symptomatic intracerebral hemorrhage as well as orolingual angioedema. Our goal is to outline the management strategies for these postthrombolysis complications.

Original language	English (US)
Pages (from-to)	133-141
Number of pages	9
Journal	The Neurohospitalist
Volume	5
Issue number	3
DOIs	https://doi.org/10.1177/1941874415587680
State	Published - Jul 2015

Keywords

cerebrovascular disorders
clinical specialty
intracranial hemorrhages
neurohospitalist
stroke

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1177/1941874415587680

Cite this

@article{60f86a4a5b3b4b6cb0009745c407991e,

title = "Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications",

abstract = "Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and shown to improve long-term functional outcomes. Its use is associated with an increased risk of symptomatic intracerebral hemorrhage as well as orolingual angioedema. Our goal is to outline the management strategies for these postthrombolysis complications.",

keywords = "cerebrovascular disorders, clinical specialty, intracranial hemorrhages, neurohospitalist, stroke",

author = "O'carroll, {Cumara B.} and Aguilar, {Maria I.}",

year = "2015",

month = jul,

doi = "10.1177/1941874415587680",

language = "English (US)",

volume = "5",

pages = "133--141",

journal = "The Neurohospitalist",

issn = "1941-8744",

publisher = "Sage Publications",

number = "3",

}

TY - JOUR

T1 - Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications

AU - O'carroll, Cumara B.

AU - Aguilar, Maria I.

PY - 2015/7

Y1 - 2015/7

N2 - Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and shown to improve long-term functional outcomes. Its use is associated with an increased risk of symptomatic intracerebral hemorrhage as well as orolingual angioedema. Our goal is to outline the management strategies for these postthrombolysis complications.

AB - Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and shown to improve long-term functional outcomes. Its use is associated with an increased risk of symptomatic intracerebral hemorrhage as well as orolingual angioedema. Our goal is to outline the management strategies for these postthrombolysis complications.

KW - cerebrovascular disorders

KW - clinical specialty

KW - intracranial hemorrhages

KW - neurohospitalist

KW - stroke

UR - http://www.scopus.com/inward/record.url?scp=84992886357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992886357&partnerID=8YFLogxK

U2 - 10.1177/1941874415587680

DO - 10.1177/1941874415587680

M3 - Review article

AN - SCOPUS:84992886357

SN - 1941-8744

VL - 5

SP - 133

EP - 141

JO - The Neurohospitalist

JF - The Neurohospitalist

IS - 3

ER -

Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this